Drug
DA-8010 clinical trials
Also written DA-8010.
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Clarithromycin (1) · Rifampin (1) · Paroxetine (1) · Mirabegron (1)
Related medicines
As reviewed, each with the page that says it.
- One of Cholinergic Antagonists source
- One of Muscarinic Antagonists source
Studies
Open first, then newest update. How each study uses DA-8010 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderCompletedPhase 3Dong-A ST Co., Ltd.NCT05282069Written as DA-8010 2.5mg
- A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010CompletedPhase 1Dong-A ST Co., Ltd.NCT05812417Written as DA-8010
- Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy AdultsCompletedPhase 1Dong-A ST Co., Ltd.NCT05991401Written as DA-8010 5mg
- Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy AdultsCompletedPhase 1Dong-A ST Co., Ltd.NCT05992428Written as DA-8010 5mg
- The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy SubjectsCompletedPhase 1Dong-A ST Co., Ltd.NCT04686825Written as DA-8010 2.5mg (Fasting)
- A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive BladderCompletedPhase 2Dong-A ST Co., Ltd.NCT03566134Written as DA-8010 2.5mg
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy SubjectsStatus unknownPhase 1Dong-A ST Co., Ltd.NCT02821312Written as DA-8010
Codes
What other systems call DA-8010 · ClinicalTrials.gg INT001078
- MeSH (NLM) C000630740DA-8010One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000630740 | DA-8010 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.